Patrick Santiago

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Many advances have been made in the treatment of acute coronary syndromes. Patients with intermediate-risk or high-risk features should receive treatment with the newer pharmacologic agents--enoxaparin, statins and, in selected cases, clopidogrel--in addition to established standard therapies (i.e., aspirin, beta-blockers, nitroglycerin, and oxygen). Use of(More)
  • 1